Exelixis(EXEL) - 2025 Q3 - Earnings Call Transcript

Exelixis (NasdaqGS:EXEL) Q3 2025 Earnings Call November 04, 2025 05:00 PM ET Company ParticipantsAnastasia Parafestas - Biotech Equity Research AssociatePJ Haley - EVP of CommercialSusan Hubbard - EVP of Public Affairs and IRDana Aftab - EVP of Research and DevelopmentChris Senner - CFOAshwani Verma - Executive Director SMID Biotech and BiopharmaNone - Company RepresentativeMichael Morrissey - President and CEOConference Call ParticipantsAsthika Goonewardene - MD, Senior Biotech AnalystNone - AnalystStephen ...